Drug Database
IB
ibuprofen + pamabrom
✓ ApprovedGC Biopharma · PTGS1 · Small Molecule
What is ibuprofen + pamabrom?
ibuprofen + pamabrom is a small molecule developed by GC Biopharma. It is approved for therapeutic indications via oral (po).
Drug Profile
| Company | GC Biopharma |
| Drug Class | Small Molecule |
| Molecular Target | PTGS1, PTGS2 |
| Route | Oral (PO) |
| Status | Approved |
Sources: ClinicalTrials.gov, GC Biopharma
Mechanism of Action
Molecular Targets
ibuprofen + pamabrom acts on 2 molecular targets:
| PTGS1 | prostaglandin-endoperoxide synthase 1 (COX3, PCOX1) |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2) |
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.
Therapeutic Indications
ibuprofen + pamabrom is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Reproductive system and breast disorders | Dysmenorrhoea | ✓ Approved |
Related Research Articles
Unable to load articles right now.